Naoya Ohmori

Title: Naoya Ohmori: Innovator in Immunosuppressive Antibodies

Introduction

Naoya Ohmori is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of immunology through his innovative research and development of monoclonal antibodies. His work focuses on creating antibodies with specific binding affinities that can be utilized in therapeutic applications.

Latest Patents

Naoya Ohmori holds a patent for a monoclonal antibody that exhibits immunosuppressive activity. The patent, titled "Monoclonal antibody having immunosuppressive activity or antigen binding fragment thereof," describes an antibody that binds to a peptide with the amino acid sequence SSVLYGGPPSAA (SEQ ID NO: 1). This invention is notable for its higher binding affinity for core histone compared to histone H1, making it a valuable asset in immunological research and potential therapies.

Career Highlights

Ohmori is affiliated with Josai University Corporation, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in treating various immune-related conditions. With a focus on developing effective immunosuppressive agents, he has positioned himself as a key figure in this specialized field.

Collaborations

Naoya Ohmori collaborates with esteemed colleagues, including Shuji Sato and Takeshi Goto. These partnerships enhance the research environment and foster innovation in the development of new therapeutic strategies.

Conclusion

Naoya Ohmori's contributions to the field of immunology through his patented monoclonal antibody highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.